Invex \u63d0\u4ea4\u7684\u4e00\u9879\u5728\u9752\u5c11\u5e74\u4e2d\u8bd5\u9a8c Presendin \u7684\u513f\u79d1\u8c03\u67e5\u8ba1\u5212<\/a>\u3002<\/p>\n\u8be5\u6279\u51c6\u5c06\u5141\u8bb8 Invex \u5f00\u5c55\u4e00\u9879\u6d89\u53ca\u591a\u8fbe 40 \u540d 18 \u5c81\u4ee5\u4e0b\u4e14\u5df2\u8fdb\u5165\u9752\u6625\u671f\u7684\u7537\u6027\u548c\u5973\u6027 IIH \u60a3\u8005\u7684\u8bd5\u9a8c\u3002<\/p>\n
\u4e3b\u8981\u7ec8\u70b9\u5c06\u7531\u5728\u8bd5\u9a8c\u8fc7\u7a0b\u4e2d\u901a\u8fc7\u5149\u5b66\u76f8\u5e72\u65ad\u5c42\u626b\u63cf\u8bc4\u4f30\u7684\u4e73\u5934\u6c34\u80bf\uff08\u89c6\u76d8\u80bf\u80c0\uff09\u7684\u53d8\u5316\u6765\u786e\u5b9a\u3002<\/p>\n
\u5173\u952e\u7684\u6b21\u8981\u7ec8\u70b9\u5c06\u5305\u62ec 24 \u5468\u65f6\u7684\u89c6\u91ce\u5e73\u5747\u504f\u5dee\u3001\u5934\u75db\u8bc4\u4f30\u548c\u89c6\u529b\uff0c\u4ee5\u53ca\u6574\u4e2a\u7814\u7a76\u8fc7\u7a0b\u4e2d\u7684\u5b89\u5168\u8bc4\u4f30\u548c\u4f34\u968f\u836f\u7269\u4f7f\u7528\u3002<\/p>\n
\u9885\u5185\u538b<\/h2>\n
IIH \u7684\u7279\u70b9\u662f\u9885\u5185\u538b\u4e25\u91cd\u5347\u9ad8\uff0c\u5bfc\u81f4\u6bcf\u5929\u5934\u75db\u5e76\u538b\u8feb\u89c6\u795e\u7ecf\u3002<\/p>\n
\u538b\u529b\u662f\u7531\u8111\u8840\u5bb9\u91cf\u3001\u8111\u810a\u6db2\u5bb9\u91cf\u6216\u8111\u7ec4\u7ec7\u5bb9\u91cf\u7684\u53d8\u5316\u5f15\u8d77\u7684\u3002<\/p>\n
\u901a\u5e38\u53d1\u75c5\u5e74\u9f84\u5728 30 \u5c81\u5de6\u53f3\uff0c\u8fd9\u79cd\u60c5\u51b5\u5728\u80a5\u80d6\u5973\u6027\u4e2d\u6700\u5e38\u89c1\u3002<\/p>\n
IIH \u662f\u4e00\u79cd\u5feb\u901f\u589e\u957f\u7684\u5b64\u513f\u9002\u5e94\u75c7\uff0c\u5176\u53d1\u75c5\u7387\u5728\u8fc7\u53bb 10 \u5e74\u4e2d\u589e\u52a0\u4e86 350% \u4ee5\u4e0a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8 Invex Therapeutics (ASX: IXC) \u5ba3\u5e03\u5728\u5fb7\u514b\u8428\u65af\u5dde\u7684 Eye Wellness Centre \u5f00\u8bbe\u5176\u5728\u7f8e\u56fd\u7684\u7b2c\u4e00\u4e2a\u4e34\u5e8a\u4e2d\u5fc3\u3002 \u8be5\u4e2d\u5fc3\u7531\u53d7\u4eba\u5c0a\u656c\u7684\u795e\u7ecf\u773c\u79d1\u533b\u751f Rose Tang \u535a\u58eb\u8fd0\u8425\uff0c\u5c06\u6210\u4e3a\u8be5\u516c\u53f8\u4e3b\u8981\u5019\u9009\u836f\u7269 Presendin\uff08\u7f13\u91ca\u827e\u585e\u90a3\u80bd\uff09\u6cbb\u7597\u9885\u5185\u538b\u5347\u9ad8\u76f8\u5173\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u8bd5\u9a8c\u7684\u7ec4\u6210\u90e8\u5206\u3002 Tang \u535a\u58eb\u4e00\u76f4\u662f\u7f8e\u56fd\u5148\u524d\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b (IIH) \u8bd5\u9a8c\u7684\u4e3b\u8981\u7814\u7a76\u8005\u3002 Invex \u9884\u8ba1\u5c06\u5728\u7f8e\u56fd\u5f00\u8bbe\u603b\u5171 10 \u4e2a\u4e34\u5e8a\u7ad9\u70b9\uff0c\u5728\u5168\u7403\u5f00\u8bbe\u591a\u8fbe 40 \u4e2a\uff0c\u8fd9\u5c06\u4e3a Presendin \u7684 IIH Evolve III \u671f\u8bd5\u9a8c\u63d0\u4f9b\u53c2\u4e0e\u8005\u3002 \u968f\u673a\u8bd5\u9a8c Evolve III \u671f\u662f\u4e00\u9879\u5b89\u6170\u5242\u5bf9\u7167\u7684\u53cc\u76f2\u7814\u7a76\uff0c\u8be5\u7814\u7a76\u5c06\u968f\u673a\u5206\u914d 240 \u540d\u65b0\u8bca\u65ad\u7684 IIH \u60a3\u8005\uff0c\u4ee5\u786e\u5b9a Presendin \u4e0e\u5b89\u6170\u5242\u76f8\u6bd4\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\uff0c\u5728 24 \u5468\u5185\u6bcf\u5468\u7ed9\u836f\u4e00\u6b21\u3002 \u4e3b\u8981\u7ec8\u70b9\u662f\u9885\u5185\u538b\u76f8\u5bf9\u4e8e\u57fa\u7ebf\u7684\u53d8\u5316\uff0c\u5173\u952e\u6b21\u8981\u7ec8\u70b9\u4e0e\u89c6\u529b\u548c\u5934\u75db\u7ed3\u679c\u6d4b\u91cf\u76f8\u5173\u3002 8 \u6708\uff0cInvex \u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40 (Food and Drug Administration; FDA) \u5bf9 Presendin \u7684\u65b0\u836f\u7814\u7a76\u7533\u8bf7\u6279\u51c6\uff0c\u5e76\u5728\u7f8e\u56fd\u5f00\u59cb\u4e86\u9488\u5bf9… Continue reading Invex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":10595,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[273],"yoast_head":"\nInvex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3<\/title>\n<meta name=\"description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8 Invex Therapeutics (ASX: IXC) \u5ba3\u5e03\u5728\u5fb7\u514b\u8428\u65af\u5dde\u7684 Eye Wellness Centre \u5f00\u8bbe\u5176\u5728\u7f8e\u56fd\u7684\u7b2c\u4e00\u4e2a\u4e34\u5e8a\u4e2d\u5fc3\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3\" \/>\n<meta property=\"og:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8 Invex Therapeutics (ASX: IXC) \u5ba3\u5e03\u5728\u5fb7\u514b\u8428\u65af\u5dde\u7684 Eye Wellness Centre \u5f00\u8bbe\u5176\u5728\u7f8e\u56fd\u7684\u7b2c\u4e00\u4e2a\u4e34\u5e8a\u4e2d\u5fc3\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-19T00:20:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:56:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IXC-idiopathic-intracranial-hypertension-IIH-phase-3-drug.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/\",\"name\":\"Invex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-01-19T00:20:40+00:00\",\"dateModified\":\"2023-08-29T17:56:46+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8 Invex Therapeutics (ASX: IXC) \u5ba3\u5e03\u5728\u5fb7\u514b\u8428\u65af\u5dde\u7684 Eye Wellness Centre \u5f00\u8bbe\u5176\u5728\u7f8e\u56fd\u7684\u7b2c\u4e00\u4e2a\u4e34\u5e8a\u4e2d\u5fc3\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3","description":"\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8 Invex Therapeutics (ASX: IXC) \u5ba3\u5e03\u5728\u5fb7\u514b\u8428\u65af\u5dde\u7684 Eye Wellness Centre \u5f00\u8bbe\u5176\u5728\u7f8e\u56fd\u7684\u7b2c\u4e00\u4e2a\u4e34\u5e8a\u4e2d\u5fc3\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3","og_description":"\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8 Invex Therapeutics (ASX: IXC) \u5ba3\u5e03\u5728\u5fb7\u514b\u8428\u65af\u5dde\u7684 Eye Wellness Centre \u5f00\u8bbe\u5176\u5728\u7f8e\u56fd\u7684\u7b2c\u4e00\u4e2a\u4e34\u5e8a\u4e2d\u5fc3\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/","og_site_name":"smallcapsCN","article_published_time":"2023-01-19T00:20:40+00:00","article_modified_time":"2023-08-29T17:56:46+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IXC-idiopathic-intracranial-hypertension-IIH-phase-3-drug.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/","url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/","name":"Invex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-01-19T00:20:40+00:00","dateModified":"2023-08-29T17:56:46+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8 Invex Therapeutics (ASX: IXC) \u5ba3\u5e03\u5728\u5fb7\u514b\u8428\u65af\u5dde\u7684 Eye Wellness Centre \u5f00\u8bbe\u5176\u5728\u7f8e\u56fd\u7684\u7b2c\u4e00\u4e2a\u4e34\u5e8a\u4e2d\u5fc3\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-opens-first-us-clinical-site-presendin-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Invex Therapeutics \u5728\u7f8e\u56fd\u5f00\u8bbe\u9996\u4e2a Presendin \u8bd5\u9a8c\u4e34\u5e8a\u4e2d\u5fc3"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6325"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6325"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6325\/revisions"}],"predecessor-version":[{"id":16204,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6325\/revisions\/16204"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10595"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}